Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. - Wikidata - awgldk - TriplyDB

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.

http://www.wikidata.org/entity/Q36267204

about

"Natural Regulators": NK Cells as Modulators of T Cell Immunity Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation The Role of Oxidative Stress and Antioxidants in Liver Diseases Immune-mediated Liver Injury in Hepatitis B Virus Infection Management of chronic hepatitis B infection: current treatment guidelines, challenges, and new developments Natural killer cells in liver disease Liver fibrosis: mechanisms of immune-mediated liver injury The L60V Variation in Hepatitis B Virus Core Protein Elicits New Epitope-Specific Cytotoxic T Lymphocytes and Enhances Viral Replication Immune therapy for hepatitis B Disease-promoting effects of type I interferons in viral, bacterial, and coinfections KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination Long-term effect on natural killer cells by interferon-α therapy on the outcomes of HCV infection.Getting "Inside" Type I IFNs: Type I IFNs in Intracellular Bacterial Infections NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection.Virus-related liver cirrhosis: molecular basis and therapeutic options.Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients.NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection.Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner Indirect action of tumor necrosis factor-alpha in liver injury during the CD8+ T cell response to an adeno-associated virus vector in mice.TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis.Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model Licensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infection Natural killer cells promote tissue injury and systemic inflammatory responses during fatal Ehrlichia-induced toxic shock-like syndrome.Inhibition of the TRAIL death receptor by CMV reveals its importance in NK cell-mediated antiviral defense.Chemokines in the immunopathogenesis of hepatitis C infection Downregulation of the AU-rich RNA-binding protein ZFP36 in chronic HBV patients: implications for anti-inflammatory therapy.TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence Natural killer cells are characterized by the concomitantly increased interferon-γ and cytotoxicity in acute resolved hepatitis B patients.Natural Killer Cells in Viral Hepatitis.Liver myofibroblasts from hepatitis B related liver failure patients may regulate natural killer cell function via PGE2.Enhanced levels of interleukin-8 are associated with hepatitis B virus infection and resistance to interferon-alpha therapy.NK cells and their ability to modulate T cells during virus infections Induction of regulatory T cells by high-dose gp96 suppresses murine liver immune hyperactivation.Pathological role of interleukin-17 in poly I:C-induced hepatitis.Human NK cell subset functions are differentially affected by adipokines Soluble MICB protein levels and platelet counts during hepatitis B virus infection and response to hepatocellular carcinoma treatment.Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B.

P2860

Q26744551-9E2242BC-12FC-4AB9-8DEF-ACD40DB35B11 Q26772036-D6FF7A48-B464-4F05-8144-877C488DCAF1 Q26779146-89236054-D9CE-45FC-8F78-F499E15973D2 Q26786772-215A7174-D726-43A6-BADA-7E498B535E7F Q27008984-BA664EE7-5A71-411C-974D-E5434E1DECF6 Q27025451-8FAC3EF1-8BBF-41CE-8BD9-D13C05980E1F Q27027766-AFB4D5B8-C3E5-4B64-8AB2-5B8CB60745BE Q27678163-1D985E1A-AF04-4E27-B535-4AA73E359F9D Q28078856-2E5D5D0C-DEA2-43E3-B007-8BC032C6E1F9 Q28082841-2B5D251D-956C-4B41-B881-1BA9027B989A Q31037177-770543D0-4B15-486B-B502-7FC38AEED7BF Q33449162-376C6DFD-D251-41B6-AFAC-CE8737AC717E Q33525552-18D6FD02-ADEE-4FF7-8248-52D914A06568 Q33588171-3E267990-4B91-40AC-A91E-A744E78D8705 Q33655568-6E768EF6-BED4-4FF1-9425-FAA0DA5E7BE0 Q33669781-F63A021D-746D-4B88-AC0F-A7051E2152FA Q33718267-A64EB025-2D40-4109-8FB9-CEC96C8C4E57 Q33734554-106CE616-70F2-4FF7-A759-75262205CE1B Q33741498-36CB02A2-33D5-4038-A6C2-DB771758D527 Q33781003-A7EA8797-6958-4B94-821E-7C335D953C06 Q33822643-88D94943-0E3A-4A1C-AB76-7B5AE95CCB85 Q33855935-B540FDDE-DABC-42A4-8B0E-6257C3A61D1C Q33912038-5DBEFADA-36F8-4537-B4C9-C0D2C89FE66A Q33927761-61D45AF4-E371-440E-8DA0-CE80BD738025 Q34005464-E9501A20-4B11-4EF4-9819-9A4388B46E22 Q34033402-1E1795A5-24A4-4B76-8061-FCC33F94C0F1 Q34047484-21963BBD-11B5-4BB2-ABD5-C1444070FBBE Q34056271-140C578F-DCB8-4BF7-9598-D333FFE5E7F3 Q34200816-4CD65278-9BCB-40CE-816C-0D8C42E1F74F Q34205905-348DD490-77F4-41EC-B2DD-7F45A4C05611 Q34469926-CE02B2F2-186E-4170-B70B-0BAF0568ABB8 Q34505690-85BDC3EE-A540-4EA4-947D-C982D7B431B3 Q34515512-9C6634DA-EEA2-4422-A539-90329F5A3877 Q34685727-83EF0577-60DC-4334-8455-3BD55AE878DC Q34700499-805B2E42-53EF-43CA-A8E2-4E70E8B7DE92 Q34852383-877B579A-C518-4163-A8EF-8841DDBCA19C Q34998903-6EC66097-38CB-491C-B10F-02F98A2A4C45 Q35010071-19A5B54D-C3DE-4994-A87E-E27DFE6962DE Q35053561-C500C8FF-65A4-4131-A908-1EE939CDA846 Q35092599-3AD1DAF2-5058-42ED-9849-9458AB749683

P2860

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.

http://www.wikidata.org/entity/Q36267204

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Cytokines induced during chron ...... NK cell-mediated liver damage.

@ast

Cytokines induced during chron ...... NK cell-mediated liver damage.

@en

type

label

Cytokines induced during chron ...... NK cell-mediated liver damage.

@ast

Cytokines induced during chron ...... NK cell-mediated liver damage.

@en

prefLabel

Cytokines induced during chron ...... NK cell-mediated liver damage.

@ast

Cytokines induced during chron ...... NK cell-mediated liver damage.

@en

P1433

Q36267204-1BEA6C3B-9598-4C0A-B3EF-F385C27DDB6C

P1476

Q36267204-8C1EA921-FD78-4766-9867-57489AF401F6

P2093

Q36267204-57EA8052-9B88-4A20-9580-9C1D79CE7673

Q36267204-5A202CE1-4F72-41E2-9BAF-0FB39C48B4F9

Q36267204-5C4DCA74-EDF6-4099-9D63-20A72DD6A224

Q36267204-A17A999A-3D14-40F8-93A2-8D5C4BCEB355

Q36267204-B8A95667-2CE2-474E-A3D9-A37EEBFE28BA

Q36267204-D4EC19B9-6075-4877-9E63-DA1FDFCFAFCF

Q36267204-D67F09D3-330D-4888-88B1-C3D2F5A04151

P2860

Q36267204-0168A872-7B20-4F37-8175-5D001FC219E8

Q36267204-04C74D6F-27E0-456C-8EBE-DA89EF886BC5

Q36267204-05511F1A-7C59-46B6-9848-5F531DBC63C4

Q36267204-092E25EF-2C55-4E99-A46C-09546372AE77

Q36267204-0D032765-8070-4D51-87DB-84A46B043B52

Q36267204-1E52224D-261A-41F4-BFFC-B6D6F5B1E4C6

Q36267204-2167B644-8FB9-4C17-8C44-A48872F22E94

Q36267204-2351741E-C2DA-48C4-9623-AD665B091D8F

Q36267204-25FC220A-3C67-419C-BA3E-6309199F8745

Q36267204-3077B40A-AEF7-4A07-BADD-04097EBF2718

P304

Q36267204-F50F4761-8649-435F-B28E-436123576C4F

P31

Q36267204-7EAE96FD-A23A-4B4B-957C-AD890463784A

P356

Q36267204-BC87ABC3-9B88-4EC5-937B-1E74694FED65

P407

Q36267204-538FE76A-9B63-41D8-BBA7-90616E31A9B7

P433

Q36267204-AE4E291F-A24B-4DF5-B573-6AF592C53193

P478

Q36267204-9CE93D76-866B-4A80-AF26-3F03FBFBA6A0

P50

Q36267204-080AB2E4-34FF-4171-BD4B-F39FA382C4C2

Q36267204-3595BEE5-FE2D-47A4-8687-18D53918413A

Q36267204-62027D8D-2A75-494E-AD29-505432BEC906

Q36267204-B0E3FDEF-D138-493F-82CB-A525D0E0341C

Q36267204-B6CE137D-A47F-40C0-9129-8C2609DDBB39

Q36267204-D8C3C886-5209-4BCD-B6B5-3D148B098388

Q36267204-DA0135A1-1497-4410-94F8-443AD3D8718D

Q36267204-F1BE36F2-182D-4633-87EB-D014C92E7AE5

P577

Q36267204-40885236-265B-442C-B443-C9003D403B49

P5875

Q36267204-ACDD49D7-05B9-49B7-8919-D11ADC9C3C4B

P698

Q36267204-9AE3247E-CB2E-4D37-A07F-94DAC984C6AC

P932

Q36267204-CA4F01E0-7518-4E8C-AF57-61160295C21D

P356

P1433

Journal of Experimental Medicine

P1476

Cytokines induced during chron ...... NK cell-mediated liver damage.

@en

P2093

A Ross Lopes

http://www.w3.org/2001/XMLSchema#string

Claire Dunn

http://www.w3.org/2001/XMLSchema#string

Gary Reynolds

http://www.w3.org/2001/XMLSchema#string

Kevin Williams

http://www.w3.org/2001/XMLSchema#string

Patrick T Kennedy

http://www.w3.org/2001/XMLSchema#string

Simon Afford

http://www.w3.org/2001/XMLSchema#string

Theodoros Christophides

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of a new member of the TNF family that induces apoptosis

Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection.

Safety and antitumor activity of recombinant soluble Apo2 ligand.

Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis

The biology of human natural killer-cell subsets.

Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver.

Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.

Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview.

P304

667-680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20061287

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

204

http://www.w3.org/2001/XMLSchema#string

P50

Persephone Borrow

Antonio Bertoletti

Pietro Lampertico

Maurizia R Brunetto

Elizabeth Humphreys

P577

2007-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236242338

http://www.w3.org/2001/XMLSchema#string

P698

17353365

http://www.w3.org/2001/XMLSchema#string

P932

2137916

http://www.w3.org/2001/XMLSchema#string